Imbruvica 140mg Capsule 90's

Imbruvica 140mg capsule contains the active ingredient ibrutinib. It is indicated for the treatment of blood cancers including mantle cell lymphoma (MCL), chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (CLL), Waldenström macroglobulinaemia, and marginal zone lymphoma (MZL). These are cancers of the white blood cells called lymphocytes that form part of the immune system. They differ from each other by the location where the cancer occurs, the type of lymphocytes affected, and certain other factors. Imbruvica 140mg capsule is also used to treat chronic graft versus host disease (cGVHD) following failure of systemic therapy. During allogeneic stem cell transplantation, the patient receives stem cells from the donor. GVHD occurs when donor cells view the patient's cells as foreign and attack them. Before taking Imbruvica 140mg capsule, discuss with your doctor if you have bleeding disorders, infection, liver problems, heart problems, or intolerance to some sugars. This medication is not recommended for adolescents and children. It is important to inform your doctor if you have recently had or are about to have any surgical procedure. Your doctor may stop Imbruvica 140mg capsule for any planned surgical or medical procedure. Use effective birth control during treatment and for at least one month after the final dose. Avoid grapefruit or oranges in any form during this treatment; they may increase the amount of drug in the blood. Drink plenty of fluid to prevent dehydration. Inform your doctor if you have diarrhoea that does not resolve.

Imbruvica 140mg capsule is used in the treatment of: Mantle cell lymphoma Chronic lymphocytic leukemia (Blood cancer) Small lymphocytic lymphoma Waldenstrom’s macroglobulinemia Chronic graft vs. host disease after failure of systemic therapy

The mechanism of action of Imbruvica 140mg Capsule involves blocking a specific protein called Bruton's tyrosine kinase (BTK), which plays a key role in the survival and growth of cancer cells. By inhibiting BTK, Imbruvica 140mg Capsule prevents the cancer cells from receiving the signals they need to grow and divide, leading to their eventual death.

Consume this medicine at the same time each day. While taking Imbruvica 140mg Capsule, do not consume grapefruit or orange in any form during the treatment. Drink plenty of fluid to prevent dehydration.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious: Bleeding problems Infections Decrease in blood cell counts Heart problems High BP Secondary cancer Tumor lysis syndrome Severe allergic reactions Common: Nausea, vomiting, diarrhea Tiredness Muscle and bone pain Rash and bruising Mouth sores Pneumonia Fever, chills Breathlessness Constipation Dizziness Body pain Swollen ankles and feet Increased creatinine levels in the blood Heavier periods and blood in urine Blurred vision Weakness and numbness

Contact your doctor immediately if you experience bleeding, infection, shortness of breath, or chest discomfort. Report to your doctor if you have had a history of heart failure or hepatitis infection. It is not recommended to take this medicine before or after surgery as it causes a delay in wound healing. Discuss effective contraceptive options with your healthcare provider and use them during treatment and for a month after the last dose of Imbruvica 140mg capsule.